Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.80 |
| ▸ | TYMS | P04818 | 3/20 | 0.78 |
| ▸ | TK1 | P04183 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thymidine Monophosphate SCHEMBL8139411 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL3984895 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL8366987 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL21257 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL18785041 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL16280929 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL2037921 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL16092807 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL7876022 | 1.00 | POLB (0.80) | POLBTYMSTK1 | |
| Thymidine Monophosphate SCHEMBL8886065 | 1.00 | POLB (0.80) | POLBTYMSTK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12290525-B2 | 5 alpha dihydrotestosterone formulations and associated methods of use and treatment | CORBOY JR EDWARD DUNNE (US) | 2025-05-06 | — | — | US | claimed |
| US-20240307410-A1 | 5 ALPHA DIHYDROTESTOSTERONE FORMULATIONS AND ASSOCIATED METHODS OF USE AND TREATMENT | CORBOY JR EDWARD DUNNE (US) | 2024-09-19 | — | — | US | claimed |
| CN-117202910-A | Formulations for prolonging pregnancy and for menstruation or pregnancy complications | 斯坦福大学托管董事会 | 2023-12-08 | — | — | CN | claimed |
| EP-3122759-B1 | CHEMICAL METHODS FOR PRODUCING TAGGED NUCLEOTIDES | UNIV COLUMBIA (US) | 2022-06-01 | — | — | EP | claimed |
| CN-119505038-B | Medium-chain inulin and preparation method and application thereof | 山东农业大学 | 2025-11-28 | — | — | CN | disclosed |
| US-12290525-B2 | 5 alpha dihydrotestosterone formulations and associated methods of use and treatment | CORBOY JR EDWARD DUNNE (US) | 2025-05-06 | — | — | US | disclosed |
| US-12290525-B2 | 5 alpha dihydrotestosterone formulations and associated methods of use and treatment | CORBOY JR EDWARD DUNNE (US) | 2025-05-06 | — | — | US | disclosed |
| CN-118496344-B | Recombinant human XVII type collagen with hair increasing and protecting effects and application thereof | 西安巨子生物基因技术股份有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119505038-A | Medium-chain inulin and preparation method and application thereof | 山东农业大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-119235729-A | Preparation method of albizia flower fermentation liquor and application of fermentation liquor in cosmetics | 杭州湃肽生化科技有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119075369-A | Preparation method of Minjiang blue snowflake extract, product and application thereof | 云南云科特色植物提取实验室有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-119074774-A | Bifidobacterium animalis subspecies BAPerfectus006 fermentation product and application thereof in anti-inflammatory, anti-photoaging and oil control | 完美（广东）日用品有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-109948428-B | GPU cluster deep learning edge computing system facing to sensing information processing | 上海理工大学 | 2022-12-09 | — | — | CN | disclosed |
| CN-115413623-A | Method for constructing polycystic ovarian syndrome-like mouse model with glycolipid metabolism abnormality | 重庆市中医院 | 2022-12-02 | — | — | CN | disclosed |
| CN-114886806-A | A cosmetic composition for preventing alopecia, and its preparation method | 广州蕴美化妆品有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-11396677-B2 | Chemical methods for producing tagged nucleotides | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2022-07-26 | — | — | US | disclosed |
| CN-114728013-A | Methods of treating prolonged pregnancy and complications of menstruation or pregnancy | 斯坦福大学托管董事会 | 2022-07-08 | — | — | CN | disclosed |
| EP-3122759-B1 | CHEMICAL METHODS FOR PRODUCING TAGGED NUCLEOTIDES | UNIV COLUMBIA (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-111228186-B | Composition for preventing alopecia and promoting hair growth and application | 上海科植倍信日化科技有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114246895-A | Acne-removing compound essential oil and preparation method thereof | 中国计量大学 | 2022-03-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11396677-B2 | Chemical methods for producing tagged nucleotides | NT5C3B, NCL, NUDT1 | POLB 178/4885TYMS 299/4885TK1 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.